Detection of extended-spectrum β-lactamases and drug sensitivity test of Klebsiella pneumoniae and Escherichia coli in lower respiratory tract specimens

褚海青,李惠萍,何国钧,瞿介明

DOI: https://doi.org/10.3969/j.issn.1001-8689.2001.06.021

2001-01-01

Abstract:Objective To investigate extended-spectrum β-lactamases (ESBLs) production and drug resistance test of Klebsiella pneumoniae and Escherichia coli in lower respiratory tract samples, and provide reference for clinical drug initiation. Methods 920 strains of Klebsiella pneumoniae and 186 strains of Escherichia coli isolated from lower respiratory tract were collected from July. 1999 to July. 2000. Double-disk synergy test was used to detect ESBLs and Kirby-Bauer agar diffusion method was used to judge drug sensitivity. Results 239 strains of Klebsiella pneumoniae and 31 strains of Escherichia coli were considered ESBLs producers, detectable rates were 25.98% and 16.67% respectively. Except imipinem, the resistant rates of ESBLs-producing strains to other 9 antibiotics were much higher than that of non-ESBLs-producing strains (P< 0.01). The resistant rates of imipinem to ESBLs-producing strains were the lowest. Conclusions The detectable rates of ESBLs-producing strains in Klebsiella pneumoniae and Escherichia coli specimens isolated from lower respiratory tract were high. The ESBLs-producing strains were all multiple-drug resistant. Imipinem was the effective antibiotic to infections caused by ESBLs-producing strains.